DiamondClear(TM) oxygen scavenger receives FDA approval - Offering customers improved package clarityDiamondClear(TM) ketchup bo
31 Janvier 2007 - 3:23PM
Business Wire
Constar�s (NASDAQ:CNST) revolutionary DiamondClear� oxygen
scavenger technology has completed the FDA�s Food Contact
Notification process and is now available for certain applications.
This achievement again demonstrates Constar�s commitment to
providing the marketplace with superior oxygen scavenging
technologies for rigid packaging and is an important step in the
evolution of DiamondClear�. Providing a high degree of clarity and
exceptional gloss, the patented DiamondClear� oxygen scavenger is
blended directly into PET (polyethylene terephthalate) to create a
highly cost effective monolayer structure. The DiamondClear�
technology provides significant design and processing freedom for
preform and bottle, without the haze that is typical of earlier
versions of PET oxygen scavenging systems. Several grades of
DiamondClear� are being developed to meet specific market
applications. Constar�s Vice President of Corporate Technologies,
Donald Deubel explained, �This patented development is another
important step forward in establishing ourselves as industry
leaders in oxygen scavenging technologies. Not only does
DiamondClear� offer superior oxygen barrier protection, it also
provides brand-owners with a "glass-like� appearance in
consumer-friendly PET.� About Constar: Philadelphia-based Constar
International Inc. is a leading global producer of PET
(polyethylene terephthalate) plastic containers for food, soft
drinks and water. The company provides full service packaging
solutions, from product design and engineering to ongoing customer
support. Its customers include many of the world�s largest consumer
product companies.
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur Constar International Inc.